SAN FRANCISCO, January 14, 2021 — Rescale, the leading hybrid HPC cloud platform enabling intelligent computing for digital R&D, was recently named to Y Combinator’s Top Companies list, reaffirming their position as a power player among startups. “We’re honored to be […]
When the global health community encountered the COVID-19 epidemic, turned pandemic, healthcare researchers get to work modeling its the spread and impact to governments and businesses. Companies like Metabiota use hundreds of different data sources to build a range of […]
While 2020 may be remembered for the unexpected tribulation it’s brought to all of us, we can’t help but count the blessings we’ve been handed by you — the scientists and engineers working behind the scenes to better this crazy […]
How does a company pivot from manufacturing vehicles (Tesla) to ventilators, or from personal computers (Apple) to personal protective equipment (PPE)? Many firms across a spectrum of industries have answered the call to pivot from their existing business models to […]
The COVID-19 global pandemic has affected all of our daily lives. Rescale is committed to the health and safety of our employees, customers, partners, and the broader community. We are following the recommendations of both the WHO and CDC, as […]
As COVID-19 spreads, researchers, engineers and scientists are in a race against time. That is where supercomputers come in. These near-unlimited compute resources speed up simulations and calculations: the more compute power you have, the more time you can save. […]
In this Big Compute Podcast episode Gabriel Broner interviews Irene Qualters about her career and the evolution of HPC. Irene, an HPC pioneer, went from being a young, inexperienced female engineer working with Seymour Cray to becoming president of Cray […]
In this Big Compute Podcast episode, Gabriel Broner hosts Mark Borodkin, COO of Bionano Genomics, to discuss how genomics and HPC enable doctors and researchers to diagnose complex diseases and prescribe unique personalized treatments based on individual variations of the […]
Guest post by Kierste Miller, Data Scientist at Metabiota At Metabiota, we are fascinated by infectious diseases and the way they spread. Epidemics pose an immense risk to the entire globe; however, they are notoriously challenging to forecast and monitor. […]
Advances in technology in the past decade have decreased the cost of sequencing the human genome significantly. With lower costs, researchers are able to perform population studies for various disorders and diseases. To perform these population studies, they will need […]